Abstract
BackgroundSeveral reports have shown that rituximab may have some efficacy in patients with active ankylosing spondylitis (AS), mainly in tumor necrosis factor alpha (TNF-α) inhibitor naïve. No direct comparisons of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have